Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.43T
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Quarter Return
+0.19%
1 Year Return
+25.4%
3 Year Return
+109.59%
5 Year Return
+197.61%
10 Year Return
+489.39%
AUM
$307B
AUM Growth
+$307B
Cap. Flow
+$15.8B
Cap. Flow %
5.13%
Top 10 Hldgs %
16.91%
Holding
4,167
New
132
Increased
2,884
Reduced
470
Closed
113

Top Buys

1
MSFT icon
Microsoft
MSFT
$440M
2
AMZN icon
Amazon
AMZN
$350M
3
INTC icon
Intel
INTC
$269M
4
AAPL icon
Apple
AAPL
$269M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
$224M

Top Sells

1
ENB icon
Enbridge
ENB
$241M
2
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
$90M
3
BIVV
Bioverativ Inc. Common Stock
BIVV
$52.3M
4
CPN
Calpine Corporation
CPN
$45.5M
5
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$40.3M

Sector Composition

1 Technology 17.84%
2 Financials 16.57%
3 Healthcare 13.16%
4 Industrials 10.27%
5 Consumer Discretionary 9.93%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
APDN icon
3701
Applied DNA Sciences
APDN
$1.66M
$158K ﹤0.01% 110,263 – –
ELP icon
3702
Copel
ELP
$6.79B
$158K ﹤0.01% 20,147 -1,223 -6% -$9.59K
LSTA icon
3703
Lisata Therapeutics
LSTA
$20.2M
$157K ﹤0.01% 26,908 – –
SCAC
3704
DELISTED
Saban Capital Acquisition Corp. Class A Ordinary Share
SCAC
$157K ﹤0.01% 15,807 – –
VDTH
3705
DELISTED
Videocon d2h Limited
VDTH
$156K ﹤0.01% 19,046 – –
EMMS
3706
DELISTED
Emmis Communications Corp
EMMS
$156K ﹤0.01% 33,957 – –
TMBR
3707
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$155K ﹤0.01% 671,686 +347,719 +107% +$80.2K
MBRX icon
3708
Moleculin Biotech
MBRX
$11.9M
$154K ﹤0.01% 85,590 – –
CLIR icon
3709
ClearSign Technologies
CLIR
$31.1M
$153K ﹤0.01% 75,989 – –
TNTR
3710
DELISTED
Tintri, Inc. Common Stock
TNTR
$153K ﹤0.01% 89,980 +10,319 +13% +$17.5K
ATLC icon
3711
Atlanticus Holdings
ATLC
$1.01B
$152K ﹤0.01% 71,490 – –
ATEC icon
3712
Alphatec Holdings
ATEC
$2.37B
$151K ﹤0.01% 47,147 – –
CLRO icon
3713
ClearOne
CLRO
$6.94M
$151K ﹤0.01% 19,107 – –
FTEK icon
3714
Fuel Tech
FTEK
$93.2M
$151K ﹤0.01% 126,541 – –
ALIM
3715
DELISTED
Alimera Sciences, Inc.
ALIM
$149K ﹤0.01% 144,795 – –
AWRE icon
3716
Aware
AWRE
$47.5M
$148K ﹤0.01% 35,720 – –
SES
3717
DELISTED
Synthesis Energy Systems Inc.
SES
$148K ﹤0.01% 55,329 +2 +0% +$5
SIOX
3718
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$147K ﹤0.01% 110,854 +7,234 +7% +$9.59K
STRM
3719
DELISTED
Streamline Health Solutions
STRM
$146K ﹤0.01% 79,728 – –
MNE
3720
DELISTED
Blackrock MUNI New York Intermediate Duration Fund, Inc.
MNE
$146K ﹤0.01% +11,360 New +$146K
RNTX
3721
Rein Therapeutics, Inc. Common Stock
RNTX
$26M
$145K ﹤0.01% 17,916 +2,636 +17% +$21.3K
ASFI
3722
DELISTED
Asta Funding Inc
ASFI
$145K ﹤0.01% 39,457 -3,434 -8% -$12.6K
ERNA icon
3723
Eterna Therapeutics
ERNA
$10.2M
$144K ﹤0.01% 21,179 – –
NNVC icon
3724
NanoViricides
NNVC
$22.7M
$144K ﹤0.01% 175,983 – –
VYNT
3725
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$144K ﹤0.01% 87,279 – –
147 148
149
150 151